Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-01-22

FDA Approved: FLUPHENAZINE HYDROCHLORIDE — Supplemental Application (PAI Holdings, LLC dba PAI Pharma)

View source ↗

Summary

FDA approved a supplemental application for Fluphenazine hydrochloride by PAI Holdings (PAI Pharma), updating the status of this generic product under ANDA 0401…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fluphenazine hydrochloride (Fluphenazine hydrochloride)

Snippet

SUPPL AP for FLUPHENAZINE HYDROCHLORIDE (FLUPHENAZINE HYDROCHLORIDE)